Literature DB >> 17998086

Minimal error in self-report of having had DXA, but self-report of its results was poor.

Suzanne M Cadarette1, Dorcas E Beaton, Monique A M Gignac, Susan B Jaglal, Leigh Dickson, Gillian A Hawker.   

Abstract

OBJECTIVE: To examine the validity of both self-report of having had dual-energy x-ray absorptiometry (DXA) and self-reported DXA test results.
METHODS: Participants were recruited in 2003 and 2004 from a population-based study of women aged 65-90 years examining osteoporosis management in Ontario, Canada (N=871). Women reporting having had a DXA were eligible and asked to report the results of their most recent test. Participant responses were compared against DXA reports obtained from physicians.
RESULTS: We obtained 413 (81%) physician records among the 510 women who reported having had a DXA test. Of these, the positive predictive value for self-report of having had a DXA was 93%. The weighted kappa statistic for the agreement between self-report and actual DXA results was 0.42 (95% confidence interval=0.34-0.49). Although 84% of those with normal bone reported this, only 29% of those with osteopenia and 62% with osteoporosis reported their results correctly. Self-report of a clinical diagnosis of osteoporosis was better among those with a low trauma fracture, yet underestimated osteoporosis prevalence by 24%.
CONCLUSION: There is minimal measurement error in self-report of having had a DXA test. Self-report of DXA results will underestimate osteoporosis prevalence and is not a good proxy for clinical diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17998086     DOI: 10.1016/j.jclinepi.2007.02.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  24 in total

Review 1.  Measuring and improving adherence to osteoporosis pharmacotherapy.

Authors:  Suzanne M Cadarette; Andrea M Burden
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

2.  Understanding Preferences for Osteoporosis Information to Develop an Osteoporosis Patient Education Brochure.

Authors:  Stephanie W Edmonds; Samantha L Solimeo; Vu-Thuy Nguyen; Nicole C Wright; Douglas W Roblin; Kenneth G Saag; Peter Cram
Journal:  Perm J       Date:  2016-11-18

3.  Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results.

Authors:  D Brask-Lindemann; S M Cadarette; P Eskildsen; B Abrahamsen
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

4.  Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators.

Authors:  Gabriela Schmajuk; Edward Yelin; Eliza Chakravarty; Lorene M Nelson; Pantelis Panopolis; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07       Impact factor: 4.794

5.  Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.

Authors:  D E Beaton; S Dyer; D Jiang; R Sujic; M Slater; J E M Sale; E R Bogoch
Journal:  Osteoporos Int       Date:  2013-06-21       Impact factor: 4.507

6.  Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study.

Authors:  Luke J Peppone; Karen M Mustian; Randy N Rosier; Jennifer K Carroll; Jason Q Purnell; Michelle C Janelsins; Gary R Morrow; Supriya G Mohile
Journal:  Support Care Cancer       Date:  2013-09-17       Impact factor: 3.603

7.  Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians.

Authors:  E Kingwell; J C Prior; P A Ratner; S M Kennedy
Journal:  Osteoporos Int       Date:  2009-06-04       Impact factor: 4.507

8.  Survivor typologies predict medical surveillance participation: the childhood cancer survivor study.

Authors:  Cheryl L Cox; Liang Zhu; Melissa M Hudson; Brenda D Steen; Leslie L Robison; Kevin C Oeffinger
Journal:  Psychooncology       Date:  2012-09-11       Impact factor: 3.894

9.  A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.

Authors:  A Cranney; M Lam; L Ruhland; R Brison; M Godwin; M M Harrison; M B Harrison; T Anastassiades; J M Grimshaw; I D Graham
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

10.  Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.

Authors:  P Cram; F D Wolinsky; Y Lou; S W Edmonds; S F Hall; D W Roblin; N C Wright; M P Jones; K G Saag
Journal:  Osteoporos Int       Date:  2016-06-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.